Molecular changes in transcription and metabolic pathways underlying muscle atrophy in the CuZnSOD null mouse model

Kavithalakshmi Sataranatarajan1, Gavin Pharaoh1, Jacob L Brown1

  • 1Aging & Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.

Geroscience
|May 13, 2020
PubMed

Insights

Mice lacking superoxide dismutase develop early sarcopenia. Elevated mitochondrial hydroperoxides precede muscle atrophy, driving molecular changes and offering potential therapeutic targets for muscle weakness.

Area of Science:

  • Aging Research
  • Mitochondrial Biology
  • Muscle Physiology

Background:

  • Mice lacking CuZn superoxide dismutase (Sod1-/-) exhibit age-related phenotypes, including sarcopenia and muscle weakness.
  • This model shows early loss of innervation contributing to muscle atrophy.

Purpose of the Study:

  • To investigate the early development of sarcopenia in Sod1-/- mice.
  • To analyze changes in muscle transcriptome, proteome, and eicosanoid profiles during sarcopenia progression.

Main Methods:

  • RNA-sequencing for transcriptomic analysis.
  • Targeted proteomics to quantify protein expression.
  • Liquid chromatography-mass spectrometry (LC-MS) for eicosanoid profiling.

Main Results:

  • Mitochondrial hydroperoxide production was significantly elevated (40%) by 2 months in Sod1-/- mice, preceding muscle atrophy.
  • Transcriptomic analysis revealed altered pathways including protein ubiquitination, synaptic potentiation, and signaling pathways.
  • Proteomics showed increased mitochondrial and antioxidant proteins, with decreased carbohydrate metabolism enzymes. Eicosanoid analysis detected 31 elevated compounds.

Conclusions:

  • Elevated mitochondrial hydroperoxide generation is an early event in Sod1-/- mice and may drive sarcopenia.
  • Molecular changes in transcriptome, proteome, and eicosanoid profiles provide insights into sarcopenia mechanisms.
  • These findings pave the way for novel therapeutic strategies targeting muscle atrophy.